MedPath

Serum fructosamine levels in mothers with gestational diabetes and its ability to predict complications in their newborn babies

Not Applicable
Conditions
Health Condition 1: O244- Gestational diabetes mellitus
Registration Number
CTRI/2024/02/063188
Lead Sponsor
DR. SHALINI NAIR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women with Gestational Diabetes Mellitus

Singleton pregnancies

At 36-38 weeks of gestation

Exclusion Criteria

Multiple gestation

Thyroid dysfunction

Steroid use

Nephrotic syndrome

Known cases of overt diabetes mellitus (type 1, type 2)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath